Dynamic changes in PD-L1 expression on circulating cancer-associated macrophage-like cells (CAML) were significantly associated with ...
Gastric cancer remains a major clinical challenge, as early symptoms are often nonspecific and many patients are diagnosed at an advanced stage, when prognosis is poor. Although PD-1 inhibitors ...
When many cancers advance, spread and reoccur, checkpoint inhibitors can help keep difficult tumors at bay. These antibody-based immunotherapies can restore the body’s ability to recognize and ...
A cell and mouse study found that a PD-L1-targeted silver, doxorubicin and manganese dioxide nanosystem increased particle ...
A new narrative review maps the rare but potentially fatal cardiovascular toxicities of immune checkpoint inhibitors, from ...
Hosted on MSN
What is PD-L1, and why does it matter?
When your care team starts discussing treatment for head and neck cancer, you may hear the term PD-L1, which stands for programmed death-ligand 1. Testing for PD-L1 helps your oncologist determine ...
Leronlimab increases PD-L1 expression on circulating tumor cells, potentially converting "cold" tumors to "hot" ones, enhancing immune response in metastatic triple-negative breast cancer. In a study, ...
BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced a clinical trial collaboration and supply agreement with Gilead ...
A protein already targeted by FDA-approved cancer drugs may also help the body fight influenza, according to new research from The Jackson Laboratory (JAX). Published in Cell Reports, the study found ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results